Page 128 - 2021_07-Haematologica-web
P. 128
Q. Zhang et al.
AB
CD
EF
GH
IJ
Figure 3. Comparison of clinical indicators changes before and 1 week after ruxolitinib therapy in the complete response group (CR, n=8) and non-CR group (n=4) respectively. For patients who discontinued ruxolitinib (RUX) within 7 days, the last known values were used as the week-1 laboratory results. For statistical analysis, the paired sample Wilcoxon signed rank test was applied.
1898
haematologica | 2021; 106(7)
